Rahlfs Capital, LLC Abb Vie Inc. Transaction History
Rahlfs Capital, LLC
- $107 Billion
- Q4 2024
A detailed history of Rahlfs Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rahlfs Capital, LLC holds 7,512 shares of ABBV stock, worth $1.45 Million. This represents 1.24% of its overall portfolio holdings.
Number of Shares
7,512Holding current value
$1.45 Million% of portfolio
1.24%Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
3,995Shares Held
1.29BCall Options Held
18.2MPut Options Held
13.6M-
Vanguard Group Inc Valley Forge, PA173MShares$33.4 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$15.3 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$9.99 Billion0.75% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.47 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $341B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...